Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2013-10-29
Product name
Black Spot Treatment Concentrated Granular Algaecide
CAS No.
87-90-1
1.2.1 Relevant identified uses
Concentrated granular algaecide
Icons in SDS
Company Information
company name
Poolwise Ltd
Section 2
Hazard statements
This product is classified as: Xn, Harmful. Xi, Irritating. N, Dangerous to the environment. Hazardous according to the criteria of SWA. Dangerous according to the Australian Dangerous Goods (ADG) Code. R8, R22, R31, R36/37/38, R50/53. Contact with combustible material may cause fire. Harmful if swallowed. Contact with acids liberates toxic gas. Irritating to eyes, respiratory system and skin. Very toxic to aquatic organisms, may cause long-term adverse effects to the aquatic environment.
Precautionary statements
S2, S8, S14, S20, S22, S26, S38, S41, S60, S61, S24/25. Keep out of reach of children. Keep container dry. Keep away from combustible materials and other readily oxidised substances. When using, do not eat or drink. Do not breathe dust. In case of contact with eyes, rinse immediately with plenty of water and contact a doctor or Poisons Information Centre. In case of insufficient ventilation, wear suitable respiratory equipment. In case of fire and/or explosion, do not breathe fumes. This material and its container must be disposed of as hazardous waste. Avoid release to the environment. Refer to special instructions/Safety Data Sheets. Avoid contact with skin and eyes.
SUSMP Classification
S6
ADG classification
Class 5.1 Oxidising substances
UN Number
2468, TRICHLOROISOCYANURIC ACID, DRY Emergency Overview Physical Description & Colour: White granular solid. Odour: Sharp chlorine/bleach-like odour.
Health hazards
irritating to eyes, respiratory system and skin, harmful if swallowed
Potential health effects
Inhalation: Short Term Exposure: Available data indicates that this product is not harmful. However product is an inhalation irritant. Symptoms may include headache, irritation of nose and throat and increased secretion of mucous in the nose and throat. Other symptoms may also become evident, but they should disappear after exposure has ceased. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product is a skin irritant. Symptoms may include itchiness and reddening of contacted skin. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. Available data shows that this product is harmful, but symptoms are not available. However, this product is an oral irritant. Symptoms may include burning sensation and reddening of skin in mouth and throat. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.